文献速递创伤骨科骨质疏松与代谢性骨病

促进英国髋部骨折临床试验:国家髋部骨折数据库与常规收集数据的作用与潜力

Facilitating clinical trials in hip fracture in the UK : the role and potential of the National Hip Fracture Database and routinely collected data.
PubMed 文献 · Bone Joint J · 2025-02-01

本研究评估了英格兰关联髋部骨折登记数据库与常规行政数据集是否适合嵌入并实施随机对照试验(RCT)。研究基于2011至2016年国家髋部骨折数据库(NHFD)队列关联医院 Episode 统计(HES)与死亡数据,并分析2014至2018年HES-国家统计办公室(ONS)数据中结局的分布。结果显示NHFD病例 ascertainment 可能超过94%,数据集稳健性、相关性与可靠性评估良好,HES-ONS结局与同期前瞻性队列研究一致,支持其用于登记嵌入、数据驱动的RCT的可行性。

要点

  • NHFD病例 ascertainment 可能超过94%,数据集稳健性、相关性和可靠性评估良好。
  • HES-ONS数据集的结局与同期采用专门数据收集框架的前瞻性队列研究一致。
  • 研究结果支持NHFD与HES-ONS用于登记嵌入、数据驱动的RCT的可行性。

核心结论

  • 研究结果支持NHFD与HES-ONS用于登记嵌入、数据驱动的RCT的可行性。

研究设计与样本

  • 首先生成2011至2016年国家髋部骨折数据库(NHFD)中髋部骨折个体队列,并关联至个人医院 Episode 统计(HES)记录和死亡数据。
  • 其次在HES中识别2014年1月至2018年12月期间的当代髋部骨折队列,以探索HES-国家统计办公室(ONS)关联数据中可用结局的可得性与分布。
  • HES-ONS数据集中结局的分布采用标准统计摘要报告;NHFD与关联HES-ONS数据集的描述性特征按临床试验转化倡议对登记支持试验的建议报告。

主要发现

  • NHFD的病例 ascertainment 可能超过94%。
  • 对数据集稳健性、相关性和可靠性的评估结果良好。
  • HES-ONS数据集的结局与同期采用专门数据收集框架的其他前瞻性队列研究一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to evaluate the suitability, against an accepted international standard, of a linked hip fracture registry and routinely collected administrative dataset in England to embed and deliver randomized controlled trials (RCTs). METHODS: First, a bespoke cohort of individuals sustaining hip fractures between 2011 and 2016 was generated from the National Hip Fracture Database (NHFD) and linked to individual Hospital Episode Statistics (HES) records and mortality data. Second, in order to explore the availability and distribution of outcomes available in linked HES-Office of National Statistics (ONS) data, a more contemporary cohort with incident hip fracture was identified within HES between January 2014 and December 2018. Distributions of the outcomes within the HES-ONS dataset were reported using standard statistical summaries; descriptive characteristics of the NHFD and linked HES-ONS dataset were reported in line with the Clinical Trials Transformation Initiative recommendations for registry-enabled trials. RESULTS: Case ascertainment of the NHFD likely exceeds 94%. The assessment of the robustness, relevance, and reliability of the datasets was favourable. Outcomes from the HES-ONS dataset were concordant with other contemporaneous prospective cohort studies with bespoke data collection frameworks. CONCLUSION: Our findings support the feasibility of the NHFD and HES-ONS to support a registry-embedded, data-enabled RCT.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Webster J, Goldacre R, Lane JCE, et al. Facilitating clinical trials in hip fracture in the UK : the role and potential of the National Hip Fracture Database and routinely collected data. Bone Joint J. 2025. PMID: 39889751. doi:10.1302/0301-620X.107B2.BJJ-2024-0846.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。